High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$582M
$582,599,106
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-04-02
$307,152
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-04-02 | $307,152 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-04-02
$923,096
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-04-02 | $923,096 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-04-02
$796,267
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-04-02 | $796,267 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-04-02
$392,468
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-04-02 | $392,468 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-04-02
$404,424
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-04-02 | $404,424 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-04-02
$629,476
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-04-02 | $629,476 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-04-02
$114,321
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-04-02 | $114,321 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-04-02
$209,087
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-04-02 | $209,087 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-04-02
$435,254
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-04-02 | $435,254 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-04-02
$197,152
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-04-02 | $197,152 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-04-02
$287,992
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-04-02 | $287,992 | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2026-04-02
$1,212,049Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2026-04-02 | $1,212,049Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $144,894 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $497,112 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $264,883 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $276,551 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $91,556 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $165,659 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $142,316 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $261,409 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $119,058 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $143,066 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $93,618 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $533,284 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $177,916 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $276,512 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $229,831 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $207,768 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $138,855 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $162,217 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $110,303 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $354,848 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $350,817 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $18,090 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-04-01 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $307,126 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-04-01 | $457,837 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $415,188 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-31 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $274,302 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $333,609 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $679,184 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $572,363 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $811,064 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $468,666 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $92,406 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $139,219 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $292,293 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $448,670 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $45,964 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $353,642 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $118,822 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-31 | $519,316 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $46,539 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-30 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $12,737 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $465,573 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $62,180 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $251,255 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $127,502 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $473,862 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $119,766 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $143,453 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $121,735 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $297,957 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $285,474 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $104,489 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $71,054 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $284,395 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $605,714 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $704,724 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $874,974 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $505,125 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $256,202 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $70,221 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $70,023 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $23,269 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2026-03-30 | $1,354,200Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
CAUSEY CHRISTOPHER
• Director
10b5-1 SellΔOwn -23.7%
2026-03-30
$786,032
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 SellΔOwn -23.7%
|
2026-03-30 | $786,032 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Other
|
2026-03-30 | $155,688 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $72,326 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $58,954 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $109,294 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $167,855 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $120,303 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $190,401 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $190,656 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $237,843 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $142,518 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $71,063 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $355,929 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $630,462 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $1,021,638Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $1,053,112Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $790,564 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $207,469 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $50,293 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-30 | $93,344 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-27 | $478,992 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-27 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-27 | $207,275 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-27 | $791,799 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-27 | $947,694 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-27 | $702,182 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-27 | $54,732 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-27 | $165,571 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-27 | $172,225 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-27 | $444,965 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-27 | $336,854 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-27 | $383,398 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-27 | $234,893 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-27 | $85,519 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $172,814 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $535,680 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $618,046 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $846,689 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $1,073,491Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $988,101 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $325,153 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $271,794 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $527,236 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2026-03-26 | $1,354,200Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-26 | $151,194 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-26 | $398,789 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-26 | $591,769 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-26 | $826,914 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-26 | $1,087,548Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-26 | $789,743 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-26 | $446,976 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-26 | $265,382 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-26 | $447,479 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-26 | $84,421 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-26 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Discretionary Sell
|
2026-03-26 | $167,994 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
Thompson Tommy G
• Director
Discretionary SellΔOwn -13.9%
2026-03-26
$762,493
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Discretionary SellΔOwn -13.9%
|
2026-03-26 | $762,493 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Discretionary Sell
|
2026-03-26 | $147,845 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Other
|
2026-03-26 | $203,600 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-25 | $197,469 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-25 | $251,431 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-25 | $203,877 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-25 | $497,148 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-25 | $840,942 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-25 | $935,672 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-25 | $994,692 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-25 | $920,433 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-25 | $237,826 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-25 | $21,549 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-25 | $64,436 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-25 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $42,882 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $286,967 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $378,827 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $1,007,763Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $854,244 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $254,752 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $148,256 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $211,208 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $358,322 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $252,447 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $134,304 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $386,133 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $275,562 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $208,740 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $62,491 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $145,348 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-24 | $20,673 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-24 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $85,804 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $235,548 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $270,506 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $342,569 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $153,387 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $311,985 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $306,177 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -10.6%
2026-03-23
$1,386,093Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -10.6%
|
2026-03-23 | $1,386,093Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $42,199 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $273,818 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $168,118 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $230,648 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $104,473 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $471,927 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $455,539 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $332,354 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $103,657 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2026-03-23 | $1,354,200Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 Sell
|
2026-03-23 | $106,000 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $198,378 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $444,149 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $491,217 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $194,067 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $356,740 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $373,232 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $181,192 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $63,309 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $337,015 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $210,173 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $339,124 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $83,550 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $688,216 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $451,308 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $470,476 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-23 | $124,413 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-23 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-20 | $952,911 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-20 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-20 | $20,814 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-20 | $271,277 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-20 | $804,810 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-20 | $169,305 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-20 | $456,708 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-20 | $523,393 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-20 | $347,200 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-20 | $1,440,969Large | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2026-03-19
$1,212,049Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2026-03-19 | $1,212,049Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-19
$422,109
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-19 | $422,109 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-19
$397,184
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-19 | $397,184 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-19
$760,382
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-19 | $760,382 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-19
$1,487,733Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-19 | $1,487,733Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-19
$942,407
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-19 | $942,407 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-19
$346,124
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-19 | $346,124 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-19
$42,672
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-19 | $42,672 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-19 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-19 | $314,524 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-19 | $461,008 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-19 | $798,863 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-19 | $655,633 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-19 | $1,032,180Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-19 | $852,557 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-19 | $21,316 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-19 | $127,656 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-19 | $760,147 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-18 | $386,441 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-18 | $458,973 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-18 | $287,190 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-18 | $173,801 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-18 | $20,915 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-18 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-18 | $86,398 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-18 | $21,506 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-18 | $222,786 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-18 | $1,454,237Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-18 | $1,355,964Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-18 | $562,907 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-17 | $70,651 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-17 | $211,298 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-17 | $355,617 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-17 | $574,737 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-17 | $388,982 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-17 | $43,274 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-17 | $421,281 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-17 | $921,830 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-17 | $587,403 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-17 | $537,318 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-17 | $986,713 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 SellΔOwn -26.5%
|
2026-03-17 | $24,008 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-17 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-16 | $299,872 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-16 | $85,979 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-16 | $409,341 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-16 | $830,704 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-16 | $950,820 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-16 | $1,347,998Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-16 | $850,660 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-16 | $106,146 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-16 | $190,498 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-16 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 Sell
|
2026-03-16 | $107,088 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-16 | $276,053 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -69.6%
2026-03-13
$259,780
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -69.6%
|
2026-03-13 | $259,780 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -55.6%
2026-03-13
$467,333
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -55.6%
|
2026-03-13 | $467,333 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -49.9%
2026-03-13
$833,702
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -49.9%
|
2026-03-13 | $833,702 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -39.4%
2026-03-13
$1,086,852Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -39.4%
|
2026-03-13 | $1,086,852Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -28.4%
2026-03-13
$1,090,707Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -28.4%
|
2026-03-13 | $1,090,707Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -17.7%
2026-03-13
$823,788
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -17.7%
|
2026-03-13 | $823,788 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-13 | $505,443 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-13 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.1%
|
2026-03-13 | $43,363 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -42.9%
2026-03-12
$669,371
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -42.9%
|
2026-03-12 | $669,371 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -19.9%
2026-03-12
$388,038
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -19.9%
|
2026-03-12 | $388,038 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.0%
2026-03-12
$579,315
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.0%
|
2026-03-12 | $579,315 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -27.4%
2026-03-12
$951,266
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -27.4%
|
2026-03-12 | $951,266 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.2%
2026-03-12
$1,047,920Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.2%
|
2026-03-12 | $1,047,920Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-12 | $31,978 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-12 | $340,582 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-12 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.0%
2026-03-12
$325,401
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.0%
|
2026-03-12 | $325,401 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -54.8%
2026-03-12
$193,388
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -54.8%
|
2026-03-12 | $193,388 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -55.8%
|
2026-03-12 | $89,312 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2026-03-12
$216,524
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2026-03-12 | $216,524 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-11 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -13.1%
2026-03-11
$130,328
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -13.1%
|
2026-03-11 | $130,328 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -73.0%
2026-03-11
$631,276
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -73.0%
|
2026-03-11 | $631,276 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -69.8%
2026-03-11
$163,428
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -69.8%
|
2026-03-11 | $163,428 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -15.8%
2026-03-11
$595,040
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.8%
|
2026-03-11 | $595,040 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -18.6%
2026-03-11
$590,121
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -18.6%
|
2026-03-11 | $590,121 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -17.5%
2026-03-11
$453,658
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -17.5%
|
2026-03-11 | $453,658 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.9%
2026-03-11
$509,664
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.9%
|
2026-03-11 | $509,664 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -39.2%
2026-03-11
$638,631
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -39.2%
|
2026-03-11 | $638,631 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -14.8%
2026-03-11
$652,390
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -14.8%
|
2026-03-11 | $652,390 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-11 | $441,512 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-11 | $128,032 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-11 | $191,566 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -28.5%
2026-03-10
$448,290
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -28.5%
|
2026-03-10 | $448,290 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.0%
|
2026-03-10 | $65,772 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.5%
2026-03-10
$218,855
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.5%
|
2026-03-10 | $218,855 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -42.5%
2026-03-10
$262,180
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -42.5%
|
2026-03-10 | $262,180 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -45.3%
2026-03-10
$510,169
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -45.3%
|
2026-03-10 | $510,169 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -16.2%
2026-03-10
$304,013
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -16.2%
|
2026-03-10 | $304,013 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.4%
2026-03-10
$216,676
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.4%
|
2026-03-10 | $216,676 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.3%
2026-03-10
$237,877
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.3%
|
2026-03-10 | $237,877 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.9%
2026-03-10
$729,322
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.9%
|
2026-03-10 | $729,322 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $303,470 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $348,036 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $246,019 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -15.3%
2026-03-10
$706,321
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.3%
|
2026-03-10 | $706,321 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $21,329 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $21,262 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $63,658 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $424,024 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-10 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -11.8%
2026-03-09
$349,720
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -11.8%
|
2026-03-09 | $349,720 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $290,919 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $347,226 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -11.6%
2026-03-09
$303,785
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -11.6%
|
2026-03-09 | $303,785 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $165,187 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $187,286 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $309,269 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.6%
2026-03-09
$458,514
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.6%
|
2026-03-09 | $458,514 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $358,075 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $124,317 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $100,010 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-09 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -13.7%
2026-03-09
$270,396
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -13.7%
|
2026-03-09 | $270,396 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -14.2%
2026-03-09
$242,203
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -14.2%
|
2026-03-09 | $242,203 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -11.9%
2026-03-09
$174,878
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -11.9%
|
2026-03-09 | $174,878 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $86,381 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $62,982 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.9%
2026-03-09
$126,384
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.9%
|
2026-03-09 | $126,384 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -54.5%
2026-03-09
$562,797
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -54.5%
|
2026-03-09 | $562,797 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -76.3%
2026-03-09
$358,561
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -76.3%
|
2026-03-09 | $358,561 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.1%
|
2026-03-09 | $42,386 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -21.6%
2026-03-06
$279,144
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -21.6%
|
2026-03-06 | $279,144 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -31.0%
2026-03-06
$579,723
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -31.0%
|
2026-03-06 | $579,723 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -35.9%
2026-03-06
$1,047,699Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -35.9%
|
2026-03-06 | $1,047,699Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.6%
2026-03-06
$419,202
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.6%
|
2026-03-06 | $419,202 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -13.8%
2026-03-06
$531,449
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -13.8%
|
2026-03-06 | $531,449 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -11.0%
2026-03-06
$474,596
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -11.0%
|
2026-03-06 | $474,596 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-06 | $114,049 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-06 | $134,038 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-06 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 Sell
|
2026-03-06 | $102,000 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -55.2%
|
2026-03-06 | $77,483 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -60.8%
2026-03-06
$217,659
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -60.8%
|
2026-03-06 | $217,659 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -21.3%
|
2026-03-06 | $96,547 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -20.3%
2026-03-06
$115,582
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -20.3%
|
2026-03-06 | $115,582 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -44.3%
2026-03-06
$450,681
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -44.3%
|
2026-03-06 | $450,681 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -15.5%
2026-03-05
$624,422
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.5%
|
2026-03-05 | $624,422 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-05 | $245,844 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-05 | $231,148 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-05 | $133,889 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-05 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-05
$346,559
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-05 | $346,559 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-05
$769,310
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-05 | $769,310 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-05
$176,429
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-05 | $176,429 | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2026-03-05
$1,212,049Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2026-03-05 | $1,212,049Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-05
$97,530
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-05 | $97,530 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-05
$361,482
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-05 | $361,482 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-05
$488,236
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-05 | $488,236 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-05
$677,403
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-05 | $677,403 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-05
$525,123
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-05 | $525,123 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-03-05
$568,114
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-03-05 | $568,114 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -81.9%
2026-03-05
$286,445
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -81.9%
|
2026-03-05 | $286,445 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -62.6%
2026-03-05
$583,938
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -62.6%
|
2026-03-05 | $583,938 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -29.4%
2026-03-05
$387,990
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -29.4%
|
2026-03-05 | $387,990 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -49.2%
2026-03-05
$1,273,121Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -49.2%
|
2026-03-05 | $1,273,121Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.4%
2026-03-05
$836,435
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.4%
|
2026-03-05 | $836,435 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -39.0%
2026-03-04
$1,121,367Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -39.0%
|
2026-03-04 | $1,121,367Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
Thompson Tommy G
• Director
Discretionary SellΔOwn -19.1%
2026-03-04
$978,839
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Discretionary SellΔOwn -19.1%
|
2026-03-04 | $978,839 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Other
|
2026-03-04 | $203,600 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 Sell
|
2026-03-04 | $9,803 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Other
|
2026-03-04 | $2,395 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
KURZWEIL RAY
• Director
Discretionary SellΔOwn -27.9%
2026-03-04
$2,401,088Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Discretionary SellΔOwn -27.9%
|
2026-03-04 | $2,401,088Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Other
|
2026-03-04 | $499,838 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.5%
|
2026-03-04 | $19,882 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -73.8%
2026-03-04
$237,976
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -73.8%
|
2026-03-04 | $237,976 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.9%
2026-03-04
$106,369
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.9%
|
2026-03-04 | $106,369 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -17.6%
|
2026-03-04 | $91,279 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -18.8%
2026-03-04
$119,663
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -18.8%
|
2026-03-04 | $119,663 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -27.3%
2026-03-04
$238,296
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -27.3%
|
2026-03-04 | $238,296 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -50.4%
2026-03-04
$886,858
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -50.4%
|
2026-03-04 | $886,858 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -29.2%
2026-03-04
$1,186,882Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -29.2%
|
2026-03-04 | $1,186,882Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.0%
2026-03-04
$451,475
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.0%
|
2026-03-04 | $451,475 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-04 | $194,083 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -49.7%
2026-03-04
$1,387,285Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -49.7%
|
2026-03-04 | $1,387,285Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -15.6%
2026-03-03
$535,362
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.6%
|
2026-03-03 | $535,362 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.5%
2026-03-03
$684,067
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.5%
|
2026-03-03 | $684,067 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.7%
2026-03-03
$528,846
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.7%
|
2026-03-03 | $528,846 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -14.5%
2026-03-03
$247,975
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -14.5%
|
2026-03-03 | $247,975 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -13.0%
2026-03-03
$190,232
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -13.0%
|
2026-03-03 | $190,232 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $105,637 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -31.4%
2026-03-03
$367,914
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -31.4%
|
2026-03-03 | $367,914 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -57.1%
2026-03-03
$458,594
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -57.1%
|
2026-03-03 | $458,594 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -19.3%
|
2026-03-03 | $66,813 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -76.4%
2026-03-03
$213,485
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -76.4%
|
2026-03-03 | $213,485 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 SellΔOwn -22.7%
|
2026-03-03 | $25,460 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-03 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $139,146 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $167,462 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $225,132 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $336,431 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $275,209 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $202,161 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-02 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -20.1%
2026-03-02
$548,117
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -20.1%
|
2026-03-02 | $548,117 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -18.2%
2026-03-02
$396,281
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -18.2%
|
2026-03-02 | $396,281 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -25.2%
2026-03-02
$450,843
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -25.2%
|
2026-03-02 | $450,843 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.1%
2026-03-02
$309,676
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.1%
|
2026-03-02 | $309,676 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -16.1%
2026-03-02
$165,550
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -16.1%
|
2026-03-02 | $165,550 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -14.3%
2026-03-02
$124,292
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -14.3%
|
2026-03-02 | $124,292 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -29.4%
2026-03-02
$218,850
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -29.4%
|
2026-03-02 | $218,850 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -29.7%
2026-03-02
$156,642
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -29.7%
|
2026-03-02 | $156,642 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -53.5%
2026-03-02
$198,289
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -53.5%
|
2026-03-02 | $198,289 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.5%
|
2026-03-02 | $83,847 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.5%
|
2026-03-02 | $21,011 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -16.5%
2026-03-02
$535,610
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -16.5%
|
2026-03-02 | $535,610 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -17.7%
2026-03-02
$697,452
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -17.7%
|
2026-03-02 | $697,452 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-02 | $369,627 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-02 | $158,936 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-02 | $217,625 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-02 | $162,208 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-02 | $81,163 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 Sell
|
2026-02-27 | $101,910 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
CAUSEY CHRISTOPHER
• Director
10b5-1 SellΔOwn -19.3%
2026-02-25
$520,000
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 SellΔOwn -19.3%
|
2026-02-25 | $520,000 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Other
|
2026-02-25 | $119,760 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-23 | $2,391,318Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-23 | $1,104,000Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-23 | $4,426,181Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-23 | $739,642 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-19
$1,004,115Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-19 | $1,004,115Large | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2026-02-19
$1,212,049Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2026-02-19 | $1,212,049Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-19
$290,357
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-19 | $290,357 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-19
$366,391
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-19 | $366,391 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-19
$136,289
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-19 | $136,289 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-19
$503,123
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-19 | $503,123 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-19
$419,255
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-19 | $419,255 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-19
$531,485
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-19 | $531,485 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-19
$702,573
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-19 | $702,573 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-17 | $3,785,935Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-17 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 SellΔOwn -18.5%
|
2026-02-17 | $23,734 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-17 | $7,031,021Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-17 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-09 | $6,941,796Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-09 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-09 | $3,737,890Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-09 | $1,149,986Large | M | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2026-02-05
$1,212,049Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2026-02-05 | $1,212,049Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-05
$1,138,810Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-05 | $1,138,810Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-05
$532,272
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-05 | $532,272 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-05
$327,725
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-05 | $327,725 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-05
$452,911
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-05 | $452,911 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-05
$1,329,824Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-05 | $1,329,824Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-02-05
$229,398
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-02-05 | $229,398 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 SellΔOwn -15.6%
|
2026-02-03 | $23,712 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-02 | $3,708,750Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-02 | $6,887,679Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-02 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-02 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-26 | $6,901,656Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-01-26 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-26 | $3,716,276Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-01-26 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $28,783 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-01-20 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $52,996 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $316,879 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $321,116 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $229,013 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $231,943 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -20.3%
2026-01-20
$1,137,768Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -20.3%
|
2026-01-20 | $1,137,768Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -23.5%
2026-01-20
$1,055,264Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -23.5%
|
2026-01-20 | $1,055,264Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -24.3%
|
2026-01-20 | $834,407 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -18.9%
|
2026-01-20 | $491,697 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.1%
|
2026-01-20 | $278,386 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -74.1%
2026-01-20
$1,367,836Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -74.1%
|
2026-01-20 | $1,367,836Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -82.1%
|
2026-01-20 | $392,704 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -85.7%
|
2026-01-20 | $73,378 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $12,240 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-01-20 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $170,345 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $172,944 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $123,244 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $124,963 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -20.3%
|
2026-01-20 | $612,430 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -23.6%
|
2026-01-20 | $568,468 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -24.3%
|
2026-01-20 | $449,296 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -18.9%
|
2026-01-20 | $264,724 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.1%
|
2026-01-20 | $149,936 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -74.1%
|
2026-01-20 | $736,347 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -82.2%
|
2026-01-20 | $211,600 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -85.7%
|
2026-01-20 | $39,511 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $6,591 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 SellΔOwn -13.5%
|
2026-01-16 | $23,049 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-15
$614,769
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-15 | $614,769 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-15
$673,918
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-15 | $673,918 | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2026-01-15
$1,212,049Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2026-01-15 | $1,212,049Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-15
$18,990
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-15 | $18,990 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-15
$742,990
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-15 | $742,990 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-15
$1,657,237Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-15 | $1,657,237Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-15
$192,219
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-15 | $192,219 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-12 | $7,012,769Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-01-12 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-12 | $3,776,107Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-01-12 | $1,149,986Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-02
$230,797
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-02 | $230,797 | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2026-01-02
$1,212,049Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2026-01-02 | $1,212,049Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-02
$97,830
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-02 | $97,830 | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Equity Compensation
2026-01-02
$0
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Equity Compensation
|
2026-01-02 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-02
$395,595
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-02 | $395,595 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-02
$1,063,803Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-02 | $1,063,803Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-02
$550,136
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-02 | $550,136 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-02
$732,894
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-02 | $732,894 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-02
$600,825
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-02 | $600,825 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2026-01-02
$357,195
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2026-01-02 | $357,195 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 SellΔOwn -10.6%
|
2025-12-23 | $25,606 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Equity Compensation
|
2025-12-22 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Other
|
2025-12-22 | $594,255 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Other
|
2025-12-22 | $625,083 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
SULLIVAN LOUIS W
• Director
Discretionary SellΔOwn -18.3%
2025-12-22
$555,700
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Discretionary SellΔOwn -18.3%
|
2025-12-22 | $555,700 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
SULLIVAN LOUIS W
• Director
Discretionary Sell
2025-12-22
$2,491,501Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Discretionary Sell
|
2025-12-22 | $2,491,501Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Equity Compensation
|
2025-12-22 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.5%
2025-12-19
$252,725
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.5%
|
2025-12-19 | $252,725 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-19 | $240,520 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.0%
2025-12-19
$761,418
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.0%
|
2025-12-19 | $761,418 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-19 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-18 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Equity Compensation
|
2025-12-18 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.0%
2025-12-18
$766,295
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.0%
|
2025-12-18 | $766,295 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.5%
2025-12-18
$254,708
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.5%
|
2025-12-18 | $254,708 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-12-18
$1,014,486Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-12-18 | $1,014,486Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-18 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Other
|
2025-12-18 | $92,638 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Discretionary Sell
|
2025-12-18 | $455,533 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.1%
2025-12-17
$1,253,367Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.1%
|
2025-12-17 | $1,253,367Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-12-17
$750,780
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-12-17 | $750,780 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-17 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-12-16
$248,585
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-12-16 | $248,585 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -60.5%
2025-12-16
$1,231,234Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -60.5%
|
2025-12-16 | $1,231,234Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-16 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.4%
2025-12-16
$494,000
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.4%
|
2025-12-16 | $494,000 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $413,958 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $78,644 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-12-15 | $513,588 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
PATUSKY CHRISTOPHER
• Director
Discretionary SellΔOwn -40.2%
2025-12-15
$495,954
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Discretionary SellΔOwn -40.2%
|
2025-12-15 | $495,954 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Other
|
2025-12-15 | $101,800 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-15 | $1,006,614Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-15 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-12-15
$245,885
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-12-15 | $245,885 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -96.4%
2025-12-15
$1,732,984Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -96.4%
|
2025-12-15 | $1,732,984Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.8%
|
2025-12-15 | $160,863 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -22.0%
|
2025-12-15 | $327,831 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-15 | $139,278 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -18.0%
|
2025-12-15 | $357,236 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -16.3%
|
2025-12-15 | $384,840 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -14.0%
|
2025-12-15 | $384,930 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -20.1%
|
2025-12-15 | $689,560 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -10.2%
|
2025-12-15 | $388,436 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-15 | $68,765 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-12-15 | $3,768,800Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-15 | $1,869,140Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.8%
|
2025-12-15 | $298,746 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -22.0%
|
2025-12-15 | $608,829 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-15 | $258,658 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -15.1%
|
2025-12-15 | $664,359 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -19.2%
|
2025-12-15 | $714,207 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -14.0%
|
2025-12-15 | $714,518 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -20.1%
2025-12-15
$1,280,472Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -20.1%
|
2025-12-15 | $1,280,472Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -10.2%
|
2025-12-15 | $721,733 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-15 | $127,707 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-12-15 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $120,573 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $119,835 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $196,745 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $99,395 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $257,869 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $178,206 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $276,968 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.6%
2025-12-12
$538,949
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.6%
|
2025-12-12 | $538,949 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.7%
2025-12-12
$1,423,834Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.7%
|
2025-12-12 | $1,423,834Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-12 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-12 | $0 | M | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2025-12-11
$1,606,330Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2025-12-11 | $1,606,330Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -75.1%
2025-12-11
$956,984
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -75.1%
|
2025-12-11 | $956,984 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-12-11
$724,682
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-12-11 | $724,682 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-11 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-12-11
$1,360,550Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-12-11 | $1,360,550Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-12-11
$542,777
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-12-11 | $542,777 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-12-11
$194,946
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-12-11 | $194,946 | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Equity Compensation
2025-12-11
$0
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
10b5-1 Sell
|
2025-12-11 | $24,149 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -80.1%
2025-12-11
$254,213
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -80.1%
|
2025-12-11 | $254,213 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-12-11
$270,044
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-12-11 | $270,044 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-12-11
$434,923
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-12-11 | $434,923 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 SellΔOwn -11.3%
2025-12-11
$2,528,076Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 SellΔOwn -11.3%
|
2025-12-11 | $2,528,076Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -51.5%
2025-12-08
$529,128
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -51.5%
|
2025-12-08 | $529,128 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -32.0%
2025-12-08
$482,920
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -32.0%
|
2025-12-08 | $482,920 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-08 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-08 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.8%
2025-12-08
$194,312
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.8%
|
2025-12-08 | $194,312 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-12-08
$244,485
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-12-08 | $244,485 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.4%
2025-12-08
$486,091
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.4%
|
2025-12-08 | $486,091 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -72.6%
2025-12-05
$1,448,810Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -72.6%
|
2025-12-05 | $1,448,810Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-05 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-05 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-12-05
$484,310
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-12-05 | $484,310 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-04 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -34.0%
2025-12-04
$672,893
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -34.0%
|
2025-12-04 | $672,893 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-04 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.2%
2025-12-04
$1,247,151Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.2%
|
2025-12-04 | $1,247,151Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.7%
2025-12-03
$781,063
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.7%
|
2025-12-03 | $781,063 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-12-03
$711,152
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-12-03 | $711,152 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-03 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -32.7%
2025-12-03
$408,873
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -32.7%
|
2025-12-03 | $408,873 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -16.0%
2025-12-02
$240,070
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -16.0%
|
2025-12-02 | $240,070 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-02 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.0%
2025-12-02
$835,989
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.0%
|
2025-12-02 | $835,989 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-02 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -29.2%
2025-12-02
$370,443
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -29.2%
|
2025-12-02 | $370,443 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-12-02
$478,640
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-12-02 | $478,640 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-01 | $436,188 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-01 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.5%
2025-12-01
$763,638
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.5%
|
2025-12-01 | $763,638 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -54.7%
2025-12-01
$670,368
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -54.7%
|
2025-12-01 | $670,368 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -45.2%
2025-12-01
$251,358
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -45.2%
|
2025-12-01 | $251,358 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-12-01
$242,340
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-12-01 | $242,340 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-12-01 | $3,066,630Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-01 | $1,363,672Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -16.0%
2025-12-01
$2,011,284Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -16.0%
|
2025-12-01 | $2,011,284Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -34.2%
2025-12-01
$3,624,368Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -34.2%
|
2025-12-01 | $3,624,368Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -26.5%
2025-12-01
$1,855,492Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -26.5%
|
2025-12-01 | $1,855,492Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -13.8%
|
2025-12-01 | $711,143 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-01 | $77,549 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-12-01 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.5%
|
2025-12-01 | $945,363 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -23.2%
2025-12-01
$1,405,815Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -23.2%
|
2025-12-01 | $1,405,815Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -46.8%
2025-12-01
$2,180,624Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -46.8%
|
2025-12-01 | $2,180,624Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -56.2%
2025-12-01
$1,396,240Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -56.2%
|
2025-12-01 | $1,396,240Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -74.7%
|
2025-12-01 | $814,440 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -59.1%
|
2025-12-01 | $163,150 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-01 | $113,120 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-12-01 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.5%
|
2025-12-01 | $509,005 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -23.2%
|
2025-12-01 | $757,272 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -46.8%
2025-12-01
$1,174,035Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -46.8%
|
2025-12-01 | $1,174,035Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -28.8%
|
2025-12-01 | $751,488 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -23.6%
|
2025-12-01 | $438,767 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-01 | $87,850 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-01 | $60,911 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -63.4%
2025-11-28
$532,797
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -63.4%
|
2025-11-28 | $532,797 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-11-28
$245,125
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-11-28 | $245,125 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-11-28 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-28 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -19.4%
2025-11-28
$388,570
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -19.4%
|
2025-11-28 | $388,570 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.3%
2025-11-28
$784,058
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.3%
|
2025-11-28 | $784,058 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -68.4%
2025-11-26
$662,838
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -68.4%
|
2025-11-26 | $662,838 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -51.7%
2025-11-26
$1,033,816Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -51.7%
|
2025-11-26 | $1,033,816Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-26 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-26
$247,803
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-26 | $247,803 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-26
$836,207
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-26 | $836,207 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-26
$1,072,182Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-26 | $1,072,182Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-26
$935,020
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-26 | $935,020 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-26
$1,632,145Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-26 | $1,632,145Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-26
$623,344
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-26 | $623,344 | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2025-11-26
$1,489,620Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2025-11-26 | $1,489,620Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-11-26 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-11-26
$243,550
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-11-26 | $243,550 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-25 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -69.8%
2025-11-25
$144,369
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -69.8%
|
2025-11-25 | $144,369 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -83.4%
2025-11-25
$1,029,351Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -83.4%
|
2025-11-25 | $1,029,351Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -37.2%
2025-11-25
$727,585
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -37.2%
|
2025-11-25 | $727,585 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $728,414 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -11.8%
2025-11-24
$1,372,575Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -11.8%
|
2025-11-24 | $1,372,575Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $930,076 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $845,233 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $132,592 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $741,168 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -20.4%
2025-11-24
$1,426,403Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -20.4%
|
2025-11-24 | $1,426,403Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -14.0%
|
2025-11-24 | $779,362 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $150,800 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $307,655 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $382,354 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $63,181 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-24 | $309,120 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-24 | $1,243,349Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-24 | $1,625,040Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-24 | $5,683,883Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-24 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-24 | $3,730,048Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $771,745 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-11-24 | $3,066,630Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $448,658 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $866,330 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.0%
2025-11-24
$708,795
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.0%
|
2025-11-24 | $708,795 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -60.5%
2025-11-24
$1,174,319Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -60.5%
|
2025-11-24 | $1,174,319Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-24 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-11-21
$709,972
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-11-21 | $709,972 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-21 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -27.8%
|
2025-11-21 | $23,804 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.2%
2025-11-21
$1,164,783Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.2%
|
2025-11-21 | $1,164,783Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-11-20
$476,803
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-11-20 | $476,803 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -69.2%
2025-11-20
$1,036,513Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -69.2%
|
2025-11-20 | $1,036,513Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-20 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -86.5%
2025-11-20
$400,208
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -86.5%
|
2025-11-20 | $400,208 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-19 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-11-19
$949,900
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-11-19 | $949,900 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-11-19
$948,436
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-11-19 | $948,436 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.0%
2025-11-18
$712,642
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.0%
|
2025-11-18 | $712,642 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.0%
2025-11-18
$472,595
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.0%
|
2025-11-18 | $472,595 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-18 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-11-18
$705,800
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-11-18 | $705,800 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $303,397 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -15.9%
|
2025-11-17 | $943,786 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -17.5%
2025-11-17
$1,252,030Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -17.5%
|
2025-11-17 | $1,252,030Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -19.1%
2025-11-17
$1,688,978Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -19.1%
|
2025-11-17 | $1,688,978Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-11-17 | $1,560,769Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.1%
2025-11-17
$1,170,802Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.1%
|
2025-11-17 | $1,170,802Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-11-17
$699,390
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-11-17 | $699,390 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-17 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $55,726 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-11-17 | $1,505,861Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $40,024 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $379,761 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $435,783 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-17 | $3,704,665Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-17 | $766,658 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-17 | $383,329 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-17 | $6,880,091Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-17 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $205,537 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -34.8%
2025-11-17
$2,139,487Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -34.8%
|
2025-11-17 | $2,139,487Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -23.9%
2025-11-17
$1,923,425Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -23.9%
|
2025-11-17 | $1,923,425Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $509,602 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-14 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-11-14
$230,170
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-11-14 | $230,170 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -55.1%
2025-11-14
$923,652
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -55.1%
|
2025-11-14 | $923,652 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -57.1%
2025-11-14
$432,304
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -57.1%
|
2025-11-14 | $432,304 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -81.4%
2025-11-14
$265,648
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -81.4%
|
2025-11-14 | $265,648 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -62.3%
2025-11-13
$1,664,100Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -62.3%
|
2025-11-13 | $1,664,100Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -83.3%
2025-11-13
$303,801
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -83.3%
|
2025-11-13 | $303,801 | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2025-11-13
$1,489,620Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2025-11-13 | $1,489,620Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-13
$91,278
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-13 | $91,278 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-13
$487,024
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-13 | $487,024 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-13
$479,819
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-13 | $479,819 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-13
$453,590
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-13 | $453,590 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-13
$918,637
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-13 | $918,637 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-13
$361,123
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-13 | $361,123 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-13
$412,153
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-13 | $412,153 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-13
$930,992
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-13 | $930,992 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-13
$969,744
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-13 | $969,744 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-11-13
$7,975
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-11-13 | $7,975 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-13 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -18.4%
2025-11-13
$348,899
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -18.4%
|
2025-11-13 | $348,899 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.6%
2025-11-13
$599,058
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.6%
|
2025-11-13 | $599,058 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-12 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -37.6%
2025-11-12
$368,915
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -37.6%
|
2025-11-12 | $368,915 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -31.5%
2025-11-12
$449,536
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -31.5%
|
2025-11-12 | $449,536 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -14.3%
2025-11-12
$237,921
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -14.3%
|
2025-11-12 | $237,921 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-11-12
$227,985
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-11-12 | $227,985 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-11-12
$463,235
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-11-12 | $463,235 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.0%
|
2025-11-12 | $92,404 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -90.7%
2025-11-11
$574,579
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -90.7%
|
2025-11-11 | $574,579 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -53.9%
2025-11-11
$738,350
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -53.9%
|
2025-11-11 | $738,350 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.6%
2025-11-11
$494,355
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.6%
|
2025-11-11 | $494,355 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-11 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-11-10 | $3,066,630Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-11-10
$224,610
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-11-10 | $224,610 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -84.8%
2025-11-10
$1,568,936Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -84.8%
|
2025-11-10 | $1,568,936Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -10.4%
|
2025-11-10 | $982,479 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-10 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -24.8%
2025-11-10
$2,102,517Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -24.8%
|
2025-11-10 | $2,102,517Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -23.8%
2025-11-10
$1,519,994Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -23.8%
|
2025-11-10 | $1,519,994Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -24.2%
2025-11-10
$1,180,598Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -24.2%
|
2025-11-10 | $1,180,598Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-10 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-10 | $6,611,870Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-10 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-10 | $3,559,813Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -12.7%
2025-11-10
$1,504,595Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -12.7%
|
2025-11-10 | $1,504,595Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-10 | $688,655 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-10 | $469,727 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-10 | $293,197 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-10 | $270,480 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-10 | $481,240 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -90.1%
2025-11-07
$533,608
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -90.1%
|
2025-11-07 | $533,608 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-07 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.0%
2025-11-07
$1,124,988Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.0%
|
2025-11-07 | $1,124,988Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -18.6%
2025-11-07
$134,412
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -18.6%
|
2025-11-07 | $134,412 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-06 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -91.2%
2025-11-06
$604,500
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -91.2%
|
2025-11-06 | $604,500 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -64.3%
2025-11-06
$1,189,808Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -64.3%
|
2025-11-06 | $1,189,808Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.0%
2025-11-05
$438,762
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.0%
|
2025-11-05 | $438,762 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-05 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -27.6%
2025-11-05
$434,297
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -27.6%
|
2025-11-05 | $434,297 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-11-05
$216,265
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-11-05 | $216,265 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-11-05
$442,262
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-11-05 | $442,262 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -30.7%
2025-11-05
$220,336
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -30.7%
|
2025-11-05 | $220,336 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-11-04 | $3,066,630Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-04 | $730,302 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -90.2%
2025-11-04
$522,079
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -90.2%
|
2025-11-04 | $522,079 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -63.4%
2025-11-04
$998,047
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -63.4%
|
2025-11-04 | $998,047 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-11-04
$216,375
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-11-04 | $216,375 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-04 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-04 | $52,741 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-04 | $157,859 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -24.2%
2025-11-04
$1,204,662Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -24.2%
|
2025-11-04 | $1,204,662Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -39.2%
2025-11-04
$3,195,910Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -39.2%
|
2025-11-04 | $3,195,910Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -24.6%
2025-11-04
$2,653,239Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -24.6%
|
2025-11-04 | $2,653,239Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-04 | $655,872 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-04 | $464,892 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-04 | $42,345 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -19.7%
2025-11-03
$1,164,868Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -19.7%
|
2025-11-03 | $1,164,868Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-03 | $416,976 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-03 | $1,980,517Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-11-03
$443,010
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-11-03 | $443,010 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -30.7%
2025-11-03
$220,695
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -30.7%
|
2025-11-03 | $220,695 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.0%
2025-11-03
$438,624
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.0%
|
2025-11-03 | $438,624 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.0%
2025-11-03
$156,359
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.0%
|
2025-11-03 | $156,359 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -27.6%
2025-11-03
$494,506
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -27.6%
|
2025-11-03 | $494,506 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-03 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -75.0%
|
2025-11-03 | $225,204 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-03 | $75,131 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-03 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-03 | $3,287,785Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -26.6%
2025-11-03
$1,268,407Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -26.6%
|
2025-11-03 | $1,268,407Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -39.8%
2025-11-03
$1,395,391Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -39.8%
|
2025-11-03 | $1,395,391Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -43.7%
|
2025-11-03 | $925,707 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -32.6%
|
2025-11-03 | $389,551 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -31.8%
|
2025-11-03 | $256,427 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -45.8%
|
2025-11-03 | $252,627 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.0%
2025-10-31
$1,112,011Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.0%
|
2025-10-31 | $1,112,011Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -17.2%
2025-10-31
$241,561
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -17.2%
|
2025-10-31 | $241,561 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-31
$447,826
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-31 | $447,826 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-31 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-30
$178,480
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-30 | $178,480 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-10-30
$225,645
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-10-30 | $225,645 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -69.8%
2025-10-30
$656,891
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -69.8%
|
2025-10-30 | $656,891 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -20.6%
2025-10-30
$242,598
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -20.6%
|
2025-10-30 | $242,598 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-10-30
$670,702
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-10-30 | $670,702 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-30 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-30
$581,243
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-30 | $581,243 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-30
$834,952
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-30 | $834,952 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-30
$1,012,579Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-30 | $1,012,579Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-30
$1,546,606Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-30 | $1,546,606Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-30
$512,706
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-30 | $512,706 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-30
$287,195
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-30 | $287,195 | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2025-10-30
$1,489,620Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2025-10-30 | $1,489,620Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.6%
2025-10-29
$476,641
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.6%
|
2025-10-29 | $476,641 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -66.0%
2025-10-29
$870,480
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -66.0%
|
2025-10-29 | $870,480 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -87.4%
2025-10-29
$395,991
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -87.4%
|
2025-10-29 | $395,991 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-29 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.2%
2025-10-28
$823,437
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.2%
|
2025-10-28 | $823,437 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.8%
2025-10-28
$211,245
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.8%
|
2025-10-28 | $211,245 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.0%
2025-10-28
$626,872
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.0%
|
2025-10-28 | $626,872 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-28 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-27 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-27
$411,954
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-27 | $411,954 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -58.0%
2025-10-27
$751,756
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -58.0%
|
2025-10-27 | $751,756 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -90.1%
2025-10-27
$498,462
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -90.1%
|
2025-10-27 | $498,462 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-27 | $6,105,886Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-27 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-27 | $894,434 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-27 | $255,552 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -98.4%
2025-10-27
$3,287,785Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -98.4%
|
2025-10-27 | $3,287,785Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -71.1%
2025-10-24
$1,243,990Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -71.1%
|
2025-10-24 | $1,243,990Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -47.2%
2025-10-24
$239,070
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -47.2%
|
2025-10-24 | $239,070 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-10-24
$213,200
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-10-24 | $213,200 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-24 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.4%
2025-10-23
$422,575
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.4%
|
2025-10-23 | $422,575 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-10-23
$212,080
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-10-23 | $212,080 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-23 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -60.5%
2025-10-23
$1,054,074Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -60.5%
|
2025-10-23 | $1,054,074Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -62.9%
2025-10-22
$928,731
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -62.9%
|
2025-10-22 | $928,731 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -90.0%
2025-10-22
$493,298
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -90.0%
|
2025-10-22 | $493,298 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-22 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -15.3%
2025-10-22
$266,578
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.3%
|
2025-10-22 | $266,578 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -46.4%
2025-10-21
$601,772
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -46.4%
|
2025-10-21 | $601,772 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.3%
2025-10-21
$462,817
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.3%
|
2025-10-21 | $462,817 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.4%
2025-10-21
$430,354
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.4%
|
2025-10-21 | $430,354 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-10-21
$216,100
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-10-21 | $216,100 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-21 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.7%
2025-10-20
$673,246
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.7%
|
2025-10-20 | $673,246 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-20 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2025-10-20 | $84,460 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -55.8%
2025-10-20
$552,512
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -55.8%
|
2025-10-20 | $552,512 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.8%
2025-10-20
$171,022
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.8%
|
2025-10-20 | $171,022 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-10-20
$217,110
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-10-20 | $217,110 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-20 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-20 | $6,250,857Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-20 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-20 | $3,365,846Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -70.2%
2025-10-17
$1,247,150Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -70.2%
|
2025-10-17 | $1,247,150Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -89.4%
2025-10-17
$475,537
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -89.4%
|
2025-10-17 | $475,537 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-17 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -86.7%
2025-10-16
$366,200
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -86.7%
|
2025-10-16 | $366,200 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-16
$435
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-16 | $435 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-16
$346,937
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-16 | $346,937 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-16
$716,061
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-16 | $716,061 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-16
$898,920
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-16 | $898,920 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-16
$1,086,199Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-16 | $1,086,199Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-16
$411,212
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-16 | $411,212 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-16
$469,136
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-16 | $469,136 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-16
$817,595
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-16 | $817,595 | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2025-10-16
$1,489,620Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2025-10-16 | $1,489,620Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-16 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-10-16
$645,338
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-10-16 | $645,338 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -62.9%
2025-10-16
$713,715
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -62.9%
|
2025-10-16 | $713,715 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-10-15
$872,944
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-10-15 | $872,944 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -31.9%
2025-10-15
$434,800
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -31.9%
|
2025-10-15 | $434,800 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-15
$433,420
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-15 | $433,420 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-15 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-10-14
$882,520
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-10-14 | $882,520 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.6%
2025-10-14
$225,890
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.6%
|
2025-10-14 | $225,890 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -41.0%
2025-10-14
$641,463
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -41.0%
|
2025-10-14 | $641,463 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-14 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.8%
2025-10-13
$1,324,200Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.8%
|
2025-10-13 | $1,324,200Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-13 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-13 | $6,440,176Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-13 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-13 | $3,467,787Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-13 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-13
$437,530
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-13 | $437,530 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.8%
2025-10-10
$1,335,830Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.8%
|
2025-10-10 | $1,335,830Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-10 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-10
$442,958
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-10 | $442,958 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-09
$445,250
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-09 | $445,250 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-10-09
$451,240
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-10-09 | $451,240 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -63.9%
2025-10-09
$899,165
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -63.9%
|
2025-10-09 | $899,165 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-09 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-10-08
$456,520
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-10-08 | $456,520 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -29.8%
2025-10-08
$386,045
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -29.8%
|
2025-10-08 | $386,045 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -30.0%
2025-10-08
$552,158
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -30.0%
|
2025-10-08 | $552,158 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-08 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -44.3%
2025-10-08
$408,726
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -44.3%
|
2025-10-08 | $408,726 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-07
$450,310
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-07 | $450,310 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -63.9%
2025-10-07
$903,730
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -63.9%
|
2025-10-07 | $903,730 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-10-07
$453,280
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-10-07 | $453,280 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-07 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-06 | $135,017 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-06 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-06
$445,240
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-06 | $445,240 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.8%
2025-10-06
$1,353,525Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.8%
|
2025-10-06 | $1,353,525Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-06 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-06 | $179,928 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-06 | $360,777 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -89.2%
2025-10-06
$5,413,011Whale
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -89.2%
|
2025-10-06 | $5,413,011Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -86.2%
|
2025-10-06 | $566,449 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-06 | $50,795 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-06 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-06 | $225,507 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -93.6%
2025-10-06
$2,994,745Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -93.6%
|
2025-10-06 | $2,994,745Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -77.8%
|
2025-10-06 | $158,728 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-06 | $45,481 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-03
$443,630
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-03 | $443,630 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -52.0%
2025-10-03
$725,902
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -52.0%
|
2025-10-03 | $725,902 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -91.3%
2025-10-03
$615,315
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -91.3%
|
2025-10-03 | $615,315 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-03 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-02
$820,566
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-02 | $820,566 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-02
$1,370,905Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-02 | $1,370,905Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-02
$834,710
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-02 | $834,710 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-02
$208,636
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-02 | $208,636 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-02
$151,959
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-02 | $151,959 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-02 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-10-02
$866,125
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-10-02 | $866,125 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-10-02
$873,400
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-10-02 | $873,400 | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2025-10-02
$1,489,620Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2025-10-02 | $1,489,620Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-02
$620,224
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-02 | $620,224 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-10-02
$795,574
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-10-02 | $795,574 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-01 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -68.1%
2025-10-01
$884,408
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -68.1%
|
2025-10-01 | $884,408 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -86.7%
2025-10-01
$360,200
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -86.7%
|
2025-10-01 | $360,200 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.1%
2025-10-01
$457,188
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.1%
|
2025-10-01 | $457,188 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-30 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -96.8%
2025-09-30
$1,691,358Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -96.8%
|
2025-09-30 | $1,691,358Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $155,374 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-09-29 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $27,999 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -59.6%
|
2025-09-29 | $41,232 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -75.2%
|
2025-09-29 | $209,603 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -43.0%
|
2025-09-29 | $208,662 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -37.2%
|
2025-09-29 | $286,316 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.6%
2025-09-29
$173,518
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.6%
|
2025-09-29 | $173,518 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2025-09-29 | $83,692 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-29 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $277,650 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $15,076 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -59.3%
|
2025-09-29 | $21,905 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -73.3%
|
2025-09-29 | $113,160 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -42.3%
|
2025-09-29 | $112,422 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -37.1%
|
2025-09-29 | $154,203 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -54.9%
|
2025-09-29 | $503,203 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -34.0%
|
2025-09-29 | $471,752 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -30.4%
|
2025-09-29 | $603,947 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -18.4%
|
2025-09-29 | $447,043 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -11.0%
|
2025-09-29 | $300,136 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $145,809 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -54.9%
|
2025-09-29 | $935,187 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -34.0%
|
2025-09-29 | $876,292 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -30.4%
2025-09-29
$1,121,434Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -30.4%
|
2025-09-29 | $1,121,434Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -18.4%
|
2025-09-29 | $829,680 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -11.0%
|
2025-09-29 | $557,036 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $288,970 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $515,635 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $270,787 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-09-29 | $1,980,517Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.5%
2025-09-29
$689,300
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.5%
|
2025-09-29 | $689,300 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -50.8%
2025-09-29
$756,017
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -50.8%
|
2025-09-29 | $756,017 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-09-26
$426,860
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-09-26 | $426,860 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-26 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.8%
2025-09-26
$1,286,031Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.8%
|
2025-09-26 | $1,286,031Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.8%
2025-09-25
$344,202
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.8%
|
2025-09-25 | $344,202 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-25 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -94.7%
2025-09-25
$993,376
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -94.7%
|
2025-09-25 | $993,376 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -21.8%
2025-09-25
$386,161
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -21.8%
|
2025-09-25 | $386,161 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -80.3%
2025-09-24
$1,438,374Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -80.3%
|
2025-09-24 | $1,438,374Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -84.0%
2025-09-24
$298,115
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -84.0%
|
2025-09-24 | $298,115 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Other
|
2025-09-24 | $119,760 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
CAUSEY CHRISTOPHER
• Director
Discretionary SellΔOwn -17.1%
2025-09-24
$440,000
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Discretionary SellΔOwn -17.1%
|
2025-09-24 | $440,000 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-24 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-23 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-09-23
$833,020
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-09-23 | $833,020 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-09-23
$839,573
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-09-23 | $839,573 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-22 | $3,278,784Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-22 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-09-22
$833,438
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-09-22 | $833,438 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-09-22
$835,775
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-09-22 | $835,775 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-09-22 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-22 | $6,089,170Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-09-22 | $1,149,986Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
Olian Judy D.
• Director
Discretionary SellΔOwn -26.3%
2025-09-19
$747,768
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Director
Discretionary SellΔOwn -26.3%
|
2025-09-19 | $747,768 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -96.8%
2025-09-19
$1,644,310Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -96.8%
|
2025-09-19 | $1,644,310Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-19 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-09-18
$489,737
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-09-18 | $489,737 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-09-18
$857,613
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-09-18 | $857,613 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-18 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-09-18
$806,535
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-09-18 | $806,535 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -52.6%
2025-09-18
$454,225
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -52.6%
|
2025-09-18 | $454,225 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -87.1%
2025-09-18
$356,905
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -87.1%
|
2025-09-18 | $356,905 | S | Form 4 |
|
UTHR
M
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
Other
2025-09-18
$1,489,620Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
Other
|
2025-09-18 | $1,489,620Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-09-18
$444,760
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-09-18 | $444,760 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-09-18
$161,000
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-09-18 | $161,000 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-09-18
$1,205,403Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-09-18 | $1,205,403Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
MAHON PAUL A
• Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
2025-09-18
$1,309,394Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
Officer • EVP & GENERAL COUNSEL
10b5-1 Sell
|
2025-09-18 | $1,309,394Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-17 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -75.9%
2025-09-17
$1,253,907Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -75.9%
|
2025-09-17 | $1,253,907Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -86.9%
2025-09-17
$346,780
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -86.9%
|
2025-09-17 | $346,780 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.8%
2025-09-16
$1,201,781Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.8%
|
2025-09-16 | $1,201,781Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-09-16
$399,281
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-09-16 | $399,281 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-16 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-15 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -55.3%
|
2025-09-15 | $828,975 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-15 | $405,091 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.5%
2025-09-15
$1,010,180Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.5%
|
2025-09-15 | $1,010,180Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -10.6%
|
2025-09-15 | $326,325 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.2%
|
2025-09-15 | $367,259 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -38.0%
|
2025-09-15 | $916,148 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -39.9%
|
2025-09-15 | $268,618 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-15 | $826,965 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -41.7%
|
2025-09-15 | $591,035 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -59.2%
2025-09-15
$2,045,227Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -59.2%
|
2025-09-15 | $2,045,227Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -25.2%
2025-09-15
$1,164,254Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -25.2%
|
2025-09-15 | $1,164,254Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -10.9%
|
2025-09-15 | $564,689 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-15 | $549,268 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-15 | $117,101 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-09-15 | $1,980,517Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -91.8%
2025-09-15
$581,356
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -91.8%
|
2025-09-15 | $581,356 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-09-15 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-15 | $41,671 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-09-12
$809,780
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-09-12 | $809,780 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -31.9%
2025-09-12
$403,910
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -31.9%
|
2025-09-12 | $403,910 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-09-12
$402,210
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-09-12 | $402,210 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-12 | $481,040 | M | Form 4 |